Literature DB >> 28562030

Switching Protein Localization by Site-Directed RNA Editing under Control of Light.

Paul Vogel1, Alfred Hanswillemenke1, Thorsten Stafforst1.   

Abstract

Site directed RNA editing is an engineered tool for the posttranscriptional manipulation of RNA and proteins. Here, we demonstrate the inclusion of additional N- and C-terminal protein domains in an RNA editing-dependent manner to switch between protein isoforms in mammalian cell culture. By inclusion of localization signals, a switch of the subcellular protein localization was achieved. This included the shift from the cytoplasm to the outer-membrane, which typically is inaccessible at the protein-level. Furthermore, the strategy allows to implement photocaging to achieve spatiotemporal control of isoform switching. The strategy does not require substantial genetic engineering, and might well complement current optogenetic and optochemical approaches.

Entities:  

Keywords:  RNA editing; epitranscriptomics; gene regulation; optogenetics; photocaging; photocontrol; protein localization

Mesh:

Substances:

Year:  2017        PMID: 28562030      PMCID: PMC5600885          DOI: 10.1021/acssynbio.7b00113

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


During expression genetic information is diversified by various mechanisms. Even when encoded in a single genetic locus, many proteins occur in several isoforms, which result from alternative promotor usage or alternative splicing. Another way of diversification is a process called RNA editing.[1,2] This refers to the insertion or deletion of nucleotides and to the enzymatic deamination of cytosine and adenosine resulting in the formation of uridine and inosine, respectively. Upon editing in the open reading frame (ORF) single amino acids can be recoded. Furthermore, RNA editing can interfere with RNA splicing, microRNA activity, and RNA stability. Such diversifications can affect almost any property of a protein including substrate specificity, catalytic efficiency, protein localization, stability, and others. As correct subcellular localization is essential for proper functioning, mislocalization can act as a strategy to control a protein’s function. One example is the cytosolic sequestering of transcription factors like NF-kB or the glucocorticoid receptors, which translocate to the nucleus in response to specific signaling cues. Synthetic biology has exploited the induction of translocation as a strategy to control genetic networks. One example for the latter is the engineered Cre-ER(T2) system for the conditional switch of gene function in vivo.[3,4] The information about the subcellular localization is typically encoded in short peptide-segments, so-called localization signals.[5] Some signals, like the nuclear localization signal (NLS), can be found anywhere in a protein. Whereas others, like the ER-targeting sequence, are typically found in the N-terminus and are proteolytically cleaved off during translation.[6] If protein isoforms differ in their localization, such signal peptides are typically in- or excluded by alternative promotor or splice sites usage. We were wondering if site-directed RNA editing could be harnessed for that purpose.[7] We and others have recently engineered artificial guideRNA-dependent editing machines that allow for the introduction of single A-to-I substitutions at targeted sites in selected transcripts inside living cells, a process called site-directed RNA editing.[8,9] To achieve this, we have fused the catalytic domain of a human adenosine deaminase acting on RNA (hADAR) with a SNAP-tag that allows for the formation of highly defined 1-to-1 covalent conjugates between the guideRNA and the deaminase.[8] The approximately 20 nt long guideRNA steers the deaminase to any arbitrary transcript in a readily programmable way. As the deaminase acts only on double-stranded RNA the guideRNA component provides the basis for substrate specificity. By chemical modification and sequence refinement, the selectivity and efficiency of the editing reaction can be further fine-tuned.[10,11] So far, we and others have applied site-directed RNA editing strategies in human cell culture,[7,9] in living organisms,[12] and in Xenopus eggs,[9] to manipulate reporter genes and to repair disease-related mutations in CFTR[9] and PINK1[13] mRNAs. Furthermore, we recently demonstrated the possibility of controlling the guideRNA–deaminase assembly by light, which enabled us to extent RNA editing by photocontrol in vivo.[12] Here, we now demonstrate a simple strategy to apply RNA editing for triggering the inclusion of an additional peptide signal into both, the N- or the C-terminus of a protein. We apply the strategy for the inclusion of a nuclear localization signal (N- or C-terminal) and for the switching between a cytoplasmic and a membrane-bound isoform in human cell culture. Furthermore, we demonstrate the light control of the isoform switch.

Results and Discussion

General Considerations

The C-terminal inclusion of an additional peptide signal appears particularly straightforward by putting the signal into the 3′-UTR directly behind an amber Stop codon (UAG), Scheme . Upon editing the Stop codon to Trp (UIG) the additional signal is inserted C-terminally. The analogous strategy at the N-terminus appears more challenging. We explore here the activation of an alternative Start codon in the 5′-UTR, as it is conceivable to edit an isoleucine codon (AUA) into a methionine/Start codon (AUI), Scheme . Prior to editing, the downstream Start codon would be used only. However, after editing the upstream Start should dominate, as cap-dependent translation typically applies the first Start codon after the cap.[14−16] Nevertheless, site-directed RNA editing inside the 5′-UTR has not yet been reported. Also within natural editing sites, editing in the 5′-UTR is strongly underrepresented.[17] Thus, it was unclear if the preinitiation complex of translation and the editing machinery will interfere. To assess both strategies in a comparable manner, we decided to start with the inclusion of a nuclear localization signal (NLS) derived from the SV 40 Large T-antigen (PKKKRKV)3, which can be put to both, the N- or C-terminus.[18] To visualize the localization phenotype, we chose the transcript of the editing enzyme (SNAP-ADAR2) as the editing target. On one hand, the enzyme is strictly localized in the cytoplasm when lacking an NLS. On the other hand, the enzyme is readily stained with fluoresceine-O6-benzylguanine (BG-FITC) to assess its localization by fluorescence microcopy.[12] Furthermore, this procedure allowed us to stay with the ectopic expression of a single construct which simplified transfection and phenotypic analysis.
Scheme 1

Three Different Constructs for Editing-Dependent Isoform Switching

The NLS has been included either N- or C-terminally into the SNAP-deaminase protein. The Igk-leader sequence, which signals plasma membrane localization, has been included N-terminally into an HA-tagged eGFP. The C-terminal platelet-derived growth factor receptor transmembrane domain (PDGFR-TMD) is a single transmembrane α-helix that anchors the protein to the plasma membrane by pointing the N-terminus outside. The expected localization phenotype (cytoplasm, nucleoplasm or outer membrane) is indicated.

Three Different Constructs for Editing-Dependent Isoform Switching

The NLS has been included either N- or C-terminally into the SNAP-deaminase protein. The Igk-leader sequence, which signals plasma membrane localization, has been included N-terminally into an HA-tagged eGFP. The C-terminal platelet-derived growth factor receptor transmembrane domain (PDGFR-TMD) is a single transmembrane α-helix that anchors the protein to the plasma membrane by pointing the N-terminus outside. The expected localization phenotype (cytoplasm, nucleoplasm or outer membrane) is indicated.

Editing-Dependent Inclusion of the NLS into the C-Terminus under Transient Expression

According to Scheme , two plasmids were constructed that contain SNAP-ADAR2 under control of the CMV promotor. In one construct, the NLS was put in frame at the C-terminus (SA-TGG-NLS). When transfected into 293T cells and BG-FITC-stained 48 h later, a clear nuclear localization was visible (Figure a). The other construct contained a single G-to-A mutation between the SNAP-ADAR and the NLS which inserts a premature Stop codon and thus shortens the open reading frame (SA-TAG-NLS). When expressed and stained comparably, a clear cytoplasmic phenotype was visible. The latter construct was the substrate to study the editing-dependent phenotype switch.
Figure 1

Editing-dependent switch from SNAP-ADAR2 to SNAP-ADAR2-NLS under transient (a) and genomic (b) expression. (a) Fluorescence imaging of FITC-stained SNAP-ADAR (green) and Hoechst 33342-stained nuclei (blue). SA-TGG-NLS is the positive control for the nuclear localization phenotype after editing. Quantitative analysis of the editing experiment: Blue shows the editing yield from Sanger sequencing. Red shows the amount of cells that are positive for SNAP-ADAR expression and show nuclear localization. mm BG-gRNA: mismatching BG-guideRNA. Black bars show the standard deviation from N = 3 independent experiments. The scale bars represent 20 μm. (b) Analogous experiment as in panel (a), but under genomic expression of the SNAP-ADAR constructs. n.d. = neither RNA editing nor nuclear localization was detectable. Further data and controls are shown in the Supporting Information, Figure S1–S3 for transient and S4–S6 for genomic expression.

Editing-dependent switch from SNAP-ADAR2 to SNAP-ADAR2-NLS under transient (a) and genomic (b) expression. (a) Fluorescence imaging of FITC-stained SNAP-ADAR (green) and Hoechst 33342-stained nuclei (blue). SA-TGG-NLS is the positive control for the nuclear localization phenotype after editing. Quantitative analysis of the editing experiment: Blue shows the editing yield from Sanger sequencing. Red shows the amount of cells that are positive for SNAP-ADAR expression and show nuclear localization. mm BG-gRNA: mismatching BG-guideRNA. Black bars show the standard deviation from N = 3 independent experiments. The scale bars represent 20 μm. (b) Analogous experiment as in panel (a), but under genomic expression of the SNAP-ADAR constructs. n.d. = neither RNA editing nor nuclear localization was detectable. Further data and controls are shown in the Supporting Information, Figure S1–S3 for transient and S4–S6 for genomic expression. For editing, 293T cells were first transfected with SA-TAG-NLS (or SA-TGG-NLS in the control) and were then reverse transfected with a guideRNA. When the matching guideRNA was used, BG-FITC staining revealed a clear appearance of nuclear SNAP-ADAR2 protein (Figure a) that resembles the phenotype of the positive control. We found this new, mixed cyto-/nucleoplasmic phenotype in 48 ± 9% of the transfected cells. Sanger sequencing revealed an editing yield of 74 ± 9%. We assume two reasons for the mixed (cytoplasmic/nuclear) phenotype after editing. First, editing was incomplete, and second, some of the stained SNAP-ADAR2 protein was old protein from the SNAP-ADAR expression prior to induction of the editing event by transfecting the guideRNA. The isoform switch was strongly dependent on editing. It did neither occur in the presence of an NH2-guideRNA incapable of conjugation,[12] nor in the presence of a BG-guideRNA with a mismatching (mm) sequence (Figure a). However, due to the high levels of SNAP-ADAR2 protein and its transcript under transient expression, low levels of guideRNA-independent editing were detectable (Figure a, graph). Even though this low-level editing did not result in a visible nuclear localization phenotype, we aimed to further improve the performance of the system by genomic integration of the SNAP-ADAR construct.

C-Terminal NLS-Inclusion Works Also under Genomic Expression

To obtain a weaker and more homogeneous expression, the respective constructs were integrated as a single copy into the genome of 293 Flip-In cells under control of the Tet-on CMV promotor (inducible genomic expression). Fluorescence microscopy confirmed the homogeneous, inducible and much weaker expression of the editase under genomic control (Figure b). Again, the cytoplasmic (SA-TAG-NLS) and nucleoplasmic (SA-TGG-NLS) phenotypes in the controls were clearly visible (Figure b). As expected, and in contrast to the conditions before, the editing was now fully dependent on the presence of the matching BG-guideRNA. Lacking the guideRNA or applying a mismatching or an NH2-guideRNA gave no detectable editing yield. The editing yield with the matching BG-guideRNA was 50 ± 8% and thus stayed a bit below that under transient expression. The same trend holds also true for the isoform switch. About 34 ± 2% of the cells showed the switch from pure cytoplasmic to a mixture of cytoplasmic and nuclear localization, demonstrating the C-terminal NLS inclusion in an editing-dependent manner under genomic expression of the construct.

Editing-Dependent Inclusion of the NLS into the N-Terminus (Transient Expression)

As depicted in Scheme , two plasmids were constructed that contain two Start codons each embedded in a strong Kozak sequence (5′-CCACC-AUG-G).[19] One of the Start codons was located in front and one behind the NLS. In the construct ATGG-NLS-SA, both Start codons are appropriate to start translation. According to the scanning model of cap-dependent translation one expects this construct to predominantly use the Start codon prior to the NLS and thus to express the full NLS-SNAP-ADAR2 protein.[14−16] Accordingly, transient expression of this construct in 293T cells showed exclusive nuclear localization of SNAP-ADAR (Figure a). The construct ATAG-NLS-SA differs from the latter by a single G-to-A mutation in the upstream Start codon, thereby creating a 5′-CCACCAUA*G sequence that is supposed to be inappropriate to start translation prior to editing (AUA*) but to turn into a strong initiation signal after editing (AUI*). Transient expression of this construct gave almost exclusive cytoplasmic localization of SNAP-ADAR. Only a small number of cells (10 ± 4%) showed a faint nuclear staining (Figure S10), which might result from a minor translation initiation from the unedited AUA Start codon, as it is embedded in a very strong sequence context. However, in a similar setting it was reported that the plasmid-borne sequence 5′-CCACCAUAG is unable to initiate translation when transfected into COS cells.[20] Clearly, the faint nuclear staining was not due to (guideRNA-independent) editing, as the editing yield in absence of the guideRNA was below the detection limit (≤2%).
Figure 2

Editing-dependent switch of SNAP-ADAR2 to NLS-SNAP-ADAR2 under transient (a) and genomic (b) expression. Experiment and analysis follows the description given in Figure . SA* marks the construct with the activated E488Q deaminase. The scale bars represent 20 μm. Further data and controls are shown in Figures S7–S9 for transient and S11–S13 for genomic expression.

Editing-dependent switch of SNAP-ADAR2 to NLS-SNAP-ADAR2 under transient (a) and genomic (b) expression. Experiment and analysis follows the description given in Figure . SA* marks the construct with the activated E488Q deaminase. The scale bars represent 20 μm. Further data and controls are shown in Figures S7–S9 for transient and S11–S13 for genomic expression. For editing, 293T cells were transfected with either of the two constructs and reverse transfected with a guideRNA. Protein localization was analyzed by fluorescence microscopy after BG-FITC staining. After transfection of the editing substrate (ATAG-NLS-SA) and the matching BG-guideRNA, we found a clearly visible nuclear staining that resembled that of the positive editing control (ATGG-NLS-SA), Figure a. Similar to the results at the 3′-UTR, we found a mixed nucleo-/cytoplasmic phenotype in 57 ± 5% of all cells. After editing the nuclear staining of the protein was much stronger compared to the occasional faint nuclear staining observed prior to editing (Figure S10). Sequencing of the mRNA revealed an editing yield of 58 ± 4%, in good agreement with the mixed phenotype. Again, the isoform switch was dependent on the editing event and did not happen in the presence of a mismatching or conjugation-incompetent NH2-guideRNA.

Editing in the 5′-UTR under Genomic Expression Requires an Activated Deaminase

Again, we tested editing under genomic expression of the 5′-UTR constructs. Upon induction, both constructs behaved as expected showing either the strict nuclear (ATGG-NLS-SA) or cytoplasmic localization (ATAG-NLS-SA) with strongly reduced but homogeneous expression over the entire culture. Compared to the expression under transient conditions, the occasional appearance of faint nuclear staining in the ATAG construct was almost abolished (below 3%). However, the editing-dependent isoform switch was disappointing. The nuclear phenotype was visible in no more than 11 ± 4% of the cells. However, this matched the low editing levels of 13 ± 1% (Figure b). The editing reaction might suffer from the comparably low concentration of editase and substrate, which might slow down the editing reaction. To test if a faster enzyme would help to improve the performance, we engineered two new cell lines that contain again either the ATAG or ATGG construct, but now with a SNAP-ADAR2* protein that contains a well-described, single point mutation in the deaminase domain (E488Q) that is reported to speed up deamination by at least 1 order of magnitude.[21] The two new constructs behaved indistinguishable from their less active counterparts in terms of expression level, homogeneity and localization phenotype. However, in the editing experiment the new constructs showed a robust isoform switch. A clear change to the mixed nuclear/cytoplasmic phenotype was found in 46 ± 4% of the cells, resulting from an improved editing yield of 42 ± 2% (Figure b). As seen before, the switch was fully dependent on editing. Consequently, the nuclear phenotype was seen in ≤4%, when no guideRNA, a mismatching guideRNA, or an NH2-guideRNA was used, reflecting the low editing yields obtained under these conditions (≤4%). Substitution of the deaminase by a more active variant boosted the performance of the system by 3-fold in terms of editing yields and number of cells with a phenotypic switch and brought the editing at the 5′-UTR to a level comparable to that at the 3′-UTR.

Isoform Switching Can Be Controlled by Light

Light is an attractive trigger to manipulate biological systems.[22] We tested if a recently introduced strategy to control the editing process by controlling the assembly reaction could be applied for the light-control of 5′-UTR editing. As described earlier, guideRNAs have been made that mask the SNAP-reactive BG moiety with the Npom photocage to render it inactive for the assembly reaction.[12] Then, the editing reaction can be started by treating the cells under the microscope with a short UV-light pulse (365 nm, 5 s). First, we studied the system with the wildtype ATAG-NLS-SA construct under transient expression. The light flash had no effect on the negative (NH2-guideRNA) and the positive editing control (BG-guideRNA) in terms of editing yield (4 ± 2% and 53 ± 1%) and localization phenotype (19 ± 4% and 57 ± 5%), Figure a. However, when applying the Npom-protected BG-guideRNA, a clear photoinduction of editing yield and isoform switch was detectable. Without irradiation, 19 ± 6% of cells showed a faint nuclear staining, whereas 53 ± 12% of the cells showed the switch to a clear nuclear staining after irradiation (Figure a). This was in accordance with the photoinduced change of editing levels from 13 ± 5% before to 40 ± 8% after irradiation. As before, the ATAG-NLS-SA construct suffered from the occasional formation of faint nuclear staining under transient expression.
Figure 3

Photoinduced switch of SNAP-ADAR2 to NLS-SNAP-ADAR2 under transient (a) and genomic (b) expression. SA* marks the construct with the activated E488Q deaminase. The scale bars represent 20 μm. Further data is shown in Figures S7–S9 for transient and Figures S11–S16 for genomic expression.

Photoinduced switch of SNAP-ADAR2 to NLS-SNAP-ADAR2 under transient (a) and genomic (b) expression. SA* marks the construct with the activated E488Q deaminase. The scale bars represent 20 μm. Further data is shown in Figures S7–S9 for transient and Figures S11–S16 for genomic expression. Thus, we also tested photocontrol under genomic expression. As before, editing yields and phenotype switching were dissatisfying with wildtype enzyme and stayed below 20% (Figure b, graph). However, the E488Q variant of the deaminase was helpful again, and the positive editing control (BG-guideRNA) gave robust nuclear staining in 46 ± 4% of the cells, matching the respective editing yields of 45 ± 4% (Figure b). The negative editing control (NH2-guideRNA) showed virtually no editing (≤4%) and also the occasional faint nuclear staining was strongly reduced (≤4%). When applying the Npom-protected guideRNA, a clear photoactivation was visible. Before irradiation 12 ± 2% of the cells showed the nuclear staining, whereas 41 ± 3% showed nuclear staining after irradiation. Again the effect was clearly depending on the editing yields which changed from 13 ± 2% before to 37 ± 5% after irradiation, see Figure b. Thus, protein isoforms can be switched by light simply by photocontrolling the assembly reaction of editase and guideRNA, both under transient and genomic expression.

5′-UTR Editing Enables to Switch Localization from the Cytoplasm to the Outer Membrane

Induction of protein translocation from the cytoplasm to the nucleoplasm under control of small molecules and/or light has been achieved earlier, either by engineering fusion proteins to become controllable by small molecules (f.i. the Cre-ER(T2) system)[23] or by the ectopic expression of proteins with site-specifically photocaged amino acids.[24−26] The latter strategies are feasible because trafficking into the nucleus is a posttranslational mechanism applied to fully folded proteins. As RNA editing happens before translation, isoform switches become feasible that are decided cotranslationally and thus are impossible to control at the protein level. A conceivable example is plasma membrane localization. The respective signal peptides are found in the very N-terminus of a protein.[5] Once the nascent signal peptide leaves the exit at the ribosome, it is recognized by the signal recognition particle that recruits the translating ribosome to the ER. At the ER, translation continues, the signal peptide is cleaved off during translation inside the ER and the protein is inserted into the membrane cotranslationally.[6] We explored how RNA editing can be used to switch protein isoforms from a cytoplasmic to a membrane-anchored localization. For this a construct was made that contains an editable Start codon (AUA*) followed by the 22 amino acid Igκ chain leader sequence, an alternative Start codon (AUG), and an HA-tagged GFP protein (Scheme ). At the very C-terminus, the construct contains the transmembrane domain (TMD) of the PDGF receptor that anchors the protein to the plasma membrane displaying the GFP and the HA-tag to the extracellular side of the cell. The analogous ATGG construct served as the positive editing control. To assess the phenotype, immunofluorescence microscopy was applied. Under transient expression (293T cells) of the positive control (ATGG), the HA-GFP is clearly localized to the outer membrane, as visualized by a rim-like anti-HA-immunostaining in fixed but not permeabilized cells (Figure a). In contrast, the negative editing control (ATAG) gave no rim-like anti-HA-staining (f.i. Figure b). However, when cells were permeabilized prior to immunostaining (Figure S21), the cytoplasmic expression of the construct was clearly detectable. When cotransfecting the ATAG construct with SNAP-ADAR2-BFP and reverse transfecting the matching BG-guideRNA, the HA-immunofluorescence showed again the rim-like staining of the outer membrane in 43 ± 2% of the cells that have been positive for GFP and BFP fluorescence (Figure c). This phenotypic switch was again clearly depending on the editing yield (64 ± 5%). It did not occur in the absence of a guideRNA or in the presence of a mismatching or NH2-guideRNA (Figure b).
Figure 4

Editing-dependent switch of HA-GFP-PDGFR-TMD localization from the cytoplasm to the plasma membrane under transient coexpression with the BFP-tagged editase (SNAP-ADAR2). Imaging was carried out after fixation, without permeabilization: HA-immunostaining with AlexaFluor-594 (red), GFP (green), and BFP (blue). (a) positive control for plasma membrane localization; (b) negative editing control; (c) editing; (d,e) light-dependent editing experiment. The scale bar represents 20 μm. Further data and controls are shown in Figures S17–S21.

Editing-dependent switch of HA-GFP-PDGFR-TMD localization from the cytoplasm to the plasma membrane under transient coexpression with the BFP-tagged editase (SNAP-ADAR2). Imaging was carried out after fixation, without permeabilization: HA-immunostaining with AlexaFluor-594 (red), GFP (green), and BFP (blue). (a) positive control for plasma membrane localization; (b) negative editing control; (c) editing; (d,e) light-dependent editing experiment. The scale bar represents 20 μm. Further data and controls are shown in Figures S17–S21.

Translocation to the Outer Membrane Can Be Controlled by Light

Finally, we tested to switch the isoforms under control of light. As before, we put the Npom photocage on the guideRNA. When applying the Npom-BG-guideRNA, a modest residual editing activity was detected (9 ± 1%), however, no outer-membrane staining was detectable (<2%, Figure d). After irradiation with 365 nm light a clear membrane staining became visible in 31 ± 3% of the cotransfected cells (Figure e). Accordingly, the editing yield increased from 9 ± 1% prior to 44 ± 5 after irradiation. UV-irradiation had no influence on the editing yield or localization phenotypes of the positive (BG-guideRNA) or negative (NH2-guideRNA) editing controls (Figures S17–S20). Overall, isoform switch from cytoplasmic to the outer membrane can be controlled at the posttranscriptional level, and photocontrol is readily included.

Conclusion and Outlook

RNA editing can be applied to switch protein isoforms. This is not restricted to the recoding of amino acids or splice sites, but can be harnessed for the inclusion of additional N- or C-terminal peptide signals by editing of Start and Stop codons. UTRs in mammals are typically around 100 nt long, but can extent to 1000 nt or longer. Thus, even the N- or C-terminal inclusion of large protein domains is conceivable.[19] Our artificial editing strategy that relies on the RNA-guided SNAP-tagged deaminases enables this without detectable interference with translation and translation initiation. It can be accomplished either under transient or genomic expression. The usage of the SNAP-deaminases further allows for a ready inclusion of light-control. The method might well complement current methods in synthetic biology, including optogenetics[27] and other optochemical approaches.[22] On one hand it enables light-controlled isoform switches that are impossible at the protein-level. This holds particularly true for phenotypes that separate already during translation and thus are inaccessible with caged or otherwise engineered proteins,[23−26] as demonstrated by the switch to an outer-membrane anchored isoform. On the other hand, the method might complement approaches that depend on the light-dependent (in)activation of genes,[28,29] which typically require massive genetic engineering. To our knowledge, this is the first report about redirecting protein localization from the cytoplasm to the membrane. In combination with light-control, our tool could provide new opportunities to address biological questions in basic research. In the future, proteins might be steered to the cell surface by using light-activated RNA editing to manipulate intracellular signaling but also extracellular events like cell–cell and cell–matrix interactions in a spatiotemporal manner.

Methods

Editing under Transient Expression

293T cells were grown in DMEM + 10% FBS + 1× P/S, 5% CO2. Plasmid transfection was done with 300 ng of the respective plasmid/well with Lipofectamine 2000 in DMEM + 10% FBS. The respective guideRNA (2.5–10 pmol/well) was reverse transfected with Lipofectamine 2000 in DMEM + 1% FBS. Cells were seeded on coverslips (DMEM + 1% FBS + HEPES). After 24 h cells were harvested for RNA sequencing or stained with BG-FITC for fluorescence microscopy as described before.[10,12]

Editing under Genomic Expression

293-Flp-In T-REx cells were induced in DMEM + 10% FBS + 15 μg/mL blasticidinS + 100 μg/mL hygromycinB + 10 ng/mL doxycycline, 5% CO2. The respective guideRNA (5–20 pmol/well) was reverse transfected with Lipofectamine 2000 in DMEM + 10% FBS + 10 ng/mL doxycycline. Cells were seeded on coverslips (DMEM + 10% FBS + HEPES + doxycycline). After 24 h cells were harvested for RNA sequencing or stained with BG-FITC for fluorescence microscopy.

Light-Induced RNA Editing

Experiments were carried out as described above with an additional irradiation step 4 h after guideRNA transfection. Cells were washed and the entire well was irradiated with 365 nm light on the microscope (Zeiss CellObserverZ1, 365 nm LED light source) for 5 s under full power at 5× magnification. Then the protocol was continued as described above.

BG-FITC Staining

To visualize the localization of SNAP-ADAR2, acetylated BG-FITC (final concentration 2 μM) was applied to the cells together with a blue Hoechst stain (Thermo Fisher, R37605) for 30 min. Cells were fixed with formaldehyde and permeabilized with 0.1% Triton X-100. Cover glasses were mounted using Shandon Immu-Mount (Thermo Fisher, USA).

Immunofluorescence Microscopy

Cells were fixed with formaldehyde and blocked with PBS + 10% FBS at 4 °C overnight. Cells were stained with a primary mouse anti-HA-antibody (Sigma-Aldrich, H9658) diluted 1:1250 in PBS + 5% FBS for 1.5 h at room temperature, and a secondary antimouse antibody conjugated to AlexaFluor-594 (Thermo Fisher, A-11005) diluted 1:1500 in PBS + 10% FBS for 45 min at room temperature. Cover glasses were mounted using Dako mounting medium (Dako North America, USA). Microscopy was performed with a Zeiss CellObserverZ1 under 600× total magnification.
  29 in total

Review 1.  Initiation of translation in prokaryotes and eukaryotes.

Authors:  M Kozak
Journal:  Gene       Date:  1999-07-08       Impact factor: 3.688

Review 2.  Conditional control of gene expression in the mouse.

Authors:  M Lewandoski
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

3.  Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing.

Authors:  Maria Fernanda Montiel-Gonzalez; Isabel Vallecillo-Viejo; Guillermo A Yudowski; Joshua J C Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-09       Impact factor: 11.205

Review 4.  Light-controlled tools.

Authors:  Clara Brieke; Falk Rohrbach; Alexander Gottschalk; Günter Mayer; Alexander Heckel
Journal:  Angew Chem Int Ed Engl       Date:  2012-07-24       Impact factor: 15.336

5.  Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA.

Authors:  Paul Vogel; Marius F Schneider; Jacqueline Wettengel; Thorsten Stafforst
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-28       Impact factor: 15.336

Review 6.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

7.  Inducible Cre mice.

Authors:  Susanne Feil; Nadejda Valtcheva; Robert Feil
Journal:  Methods Mol Biol       Date:  2009

8.  Genetically encoded photocontrol of protein localization in mammalian cells.

Authors:  Arnaud Gautier; Duy P Nguyen; Hrvoje Lusic; Wenlin An; Alexander Deiters; Jason W Chin
Journal:  J Am Chem Soc       Date:  2010-03-31       Impact factor: 15.419

Review 9.  Classical nuclear localization signals: definition, function, and interaction with importin alpha.

Authors:  Allison Lange; Ryan E Mills; Christopher J Lange; Murray Stewart; Scott E Devine; Anita H Corbett
Journal:  J Biol Chem       Date:  2006-12-14       Impact factor: 5.157

10.  Control of protein function through optochemical translocation.

Authors:  Hanna Engelke; Chungjung Chou; Rajendra Uprety; Phillip Jess; Alexander Deiters
Journal:  ACS Synth Biol       Date:  2014-02-26       Impact factor: 5.110

View more
  9 in total

Review 1.  A-to-I RNA editing - immune protector and transcriptome diversifier.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

Review 2.  Off-Target Editing by CRISPR-Guided DNA Base Editors.

Authors:  SeHee Park; Peter A Beal
Journal:  Biochemistry       Date:  2019-08-26       Impact factor: 3.162

3.  Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo.

Authors:  Zongyi Yi; Liang Qu; Huixian Tang; Zhiheng Liu; Ying Liu; Feng Tian; Chunhui Wang; Xiaoxue Zhang; Ziqi Feng; Ying Yu; Pengfei Yuan; Zexuan Yi; Yanxia Zhao; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2022-02-10       Impact factor: 68.164

4.  Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs.

Authors:  Liang Qu; Zongyi Yi; Shiyou Zhu; Chunhui Wang; Zhongzheng Cao; Zhuo Zhou; Pengfei Yuan; Ying Yu; Feng Tian; Zhiheng Liu; Ying Bao; Yanxia Zhao; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2019-07-15       Impact factor: 54.908

Review 5.  Base editing: precision chemistry on the genome and transcriptome of living cells.

Authors:  Holly A Rees; David R Liu
Journal:  Nat Rev Genet       Date:  2018-12       Impact factor: 53.242

Review 6.  Base editing: advances and therapeutic opportunities.

Authors:  Elizabeth M Porto; Alexis C Komor; Ian M Slaymaker; Gene W Yeo
Journal:  Nat Rev Drug Discov       Date:  2020-10-19       Impact factor: 112.288

7.  RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease.

Authors:  Maria Birgaoanu; Marco Sachse; Aikaterini Gatsiou
Journal:  Cardiovasc Drugs Ther       Date:  2022-10-14       Impact factor: 3.947

8.  Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing.

Authors:  Xinyun Jing; Bingran Xie; Longxian Chen; Niubing Zhang; Yiyi Jiang; Hang Qin; Hongbing Wang; Pei Hao; Sheng Yang; Xuan Li
Journal:  Nucleic Acids Res       Date:  2018-09-06       Impact factor: 16.971

9.  RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.

Authors:  Sonali Bhakta; Matomo Sakari; Toshifumi Tsukahara
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.